Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch Psychiatr Nurs ; 30(2): 167-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26992866

RESUMO

Persons living with a mental illness represent an especially vulnerable and disadvantaged subgroup of smokers. Compared to those in the general population, they smoke more, die younger, and suffer disproportionately from cardiovascular disease, diabetes, stroke, and cancer, all diseases and conditions directly associated with, and exacerbated by, smoking. Despite strong evidence that tobacco cessation counseling by a health professional can approximately double patients' odds of quitting, clinicians across disciplines are reluctant to offer these individuals effective means by which to quit smoking. This disinclination is due, at least in part, to inadequate tobacco cessation training during degree education. The purpose of this qualitative study was to assess undergraduate nursing students' perceptions of a tobacco education intervention. Findings support the integration of tobacco education into undergraduate nursing curricula.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Enfermagem Psiquiátrica/educação , Estudantes de Enfermagem/psicologia , Uso de Tabaco , Currículo , Humanos , Transtornos Mentais , Pesquisa Qualitativa , Abandono do Hábito de Fumar/psicologia
4.
J Infect Dis ; 191(7): 1123-8, 2005 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-15747248

RESUMO

Because of the highly neurotropic and neurovirulent properties of wild-type mumps viruses, most national regulatory organizations require neurovirulence testing of virus seeds used in the production of mumps vaccines. Such testing has historically been performed in monkeys; however, some data suggest that testing in monkeys does not necessarily discriminate among the relative neurovirulent risks of mumps virus strains. To address this problem, a collaborative study was initiated by the National Institute for Biological Standards and Control in the United Kingdom and the Food and Drug Administration in the United States, to test a novel rat-based mumps virus neurovirulence safety test. Results indicate that the assay correctly assesses the neurovirulence potential of mumps viruses in humans and is robust and reproducible.


Assuntos
Encéfalo/virologia , Vacina contra Caxumba/efeitos adversos , Vírus da Caxumba/patogenicidade , Virologia/métodos , Virulência , Animais , Encéfalo/patologia , Humanos , Ratos , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...